+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare CRO Services Market, by Service Type, by End User, by Therapeutic Area, by Region, Industry Analysis and Forecast, 2019 - 2025

  • ID: 5017699
  • Report
  • March 2020
  • Region: Global
  • 255 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • ICON PLC
  • IQVIA Holdings, Inc.
  • Syneos Health, Inc.
  • MORE
The Global Healthcare CRO Market size is expected to reach $57.1 billion by 2025, rising at a market growth of 6.8% CAGR during the forecast period. Contract research organizations (CRO) are the companies that provide contract-based research services to several pharmaceutical & biotechnology industries, medical devices industries, and various government research organizations. Such facilities include research and development of medicines & devices, i.e. pre-discovery, CMS, preclinical research, clinical trials, post-marketing monitoring, and laboratory facilities.

Through globalization and rapid technological advancements enable many biotech and pharmaceutical companies to outsource their research production to many contract research organizations. In addition, investments by many main players in various clinical & non-clinical research activities outsourced by many contract research organizations services that aid in cost-effective production product options is expected to propel the growth of the global market for CRO services over the forecast period.

Healthcare project management helps companies improve and function more efficiently in several ways. Perhaps the greatest advantage of hospital project management is that it can minimize the possibility of litigation that prevails for every organization in healthcare. Step by step establishing processes removes as many adverse results as possible. Managing a project aligns money with the operation. In other words, it guarantees at various points of a project that you have the money for your efforts. You'll know, for example, if you have the budget to start a project. As and when additional costs occur, it is important to have a mechanism in place to update the budget and re-prioritize as appropriate.

With the sudden break of Covid-19 in late months of year 2019, the markets worldwide are unfortunately experiencing its grip. The suppliers and consumers of the products & Services are affected in a big way across the sectors resulting in declining revenues in last quarters of year 2019.

Based on Service Type, the market is segmented into Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services. Based on End User, the market is segmented into Pharmaceutical companies, Medical Device Companies and Academic Institutes. Based on Therapeutic Area, the market is segmented into Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are partnerships and Acquisitions. Based on the Analysis presented in the Cardinal matrix, ICON PLC, Dassault Systemes SE, Laboratory Corporation of America Holdings, IQVIA Holdings, Inc., and Charles River Laboratories International, Inc. are the forerunners in the Healthcare CRO Services Market. Companies such as Pharmaceutical Product Development, Inc., Pharmaron Beijing Co., Ltd., Parexel International Corporation, and Syneos Health, Inc., and GVK Biosciences Private Limited are some of the key innovators in Healthcare CRO Services Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.

Recent strategies deployed in Healthcare CRO Services Market

Partnerships, Collaborations, and Agreements:

Mar-2020: Medidata signed an agreement with Medpace Inc. for integrating Medidata Rave Imaging with Medpace's imaging systems and workflow. The combination is expected to create a seamless platform for capturing, managing, analyzing, and storing images and imaging data for clinical trials.

Jan-2020: Aragen Bioscience, Inc, a subsidiary unit of GVK BIO collaborated with Serum Institute of India Pvt. Ltd. (Serum), the world's largest vaccine manufacturer. Following the collaboration, the companies is expected to develop multiple stable cell lines for supporting Serum's HIV program.

Dec-2019: Paerxel International signed an agreement with Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company. The agreement was aimed at Clinical Development Services. Parexel's Biotech division is expected to conduct a Phase 1 study for evaluating the bioavailability of TABMELT technology and provide regulatory support for Vivera's IND process.

Nov-2019: Syneos Health signed a partnership agreement with AiCure, an AI and advanced data analytics company. The partnership drives faster and smarter trials for optimizing patient engagement.

Oct-2019: Parexel came into partnership with Datavant, a company that provides solutions for helping institutions protect, match, and share health data. The partnership was aimed to connect real-world data across the clinical trials Parexel conducts.

Sep-2019: Parexel announced partnership with three prominent healthcare institutions: PKUCare Luzhong Hospital, West China Medical Center, and Shanghai Xuhui Central Hospital. The partnership is expected to deliver an enhanced level of support for customers conducting Phase I studies in China.

Aug-2019: Pharmaceutical Product Development, LLC (PPD) collaborated with Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company. The collaboration was focused on developing HBM's innovative therapeutics in the fields of oncology and immunology.

Aug-2019: Evidera, a business of Pharmaceutical Product Development, LLC (PPD) teamed up with Clinical Study Support, Inc. (CSS), a subsidiary of Shin Nippon Biomedical Laboratories Ltd. (SNBL). The collaboration aimed to broaden the capabilities of both organizations for providing more robust consulting and analytical capabilities and creating a more complete geographic customer solution for clinical, real-world and patient-centered research.

Jul-2019: Medidata teamed up with Catalyst Clinical Research following which the latter company chose the Medidata Rave Clinical Cloud for its one-platform approach to clinical trials. Catalyst aims to offer a data-driven, state-of-the-art unified clinical platform as it launches its new CRO full-service managed solutions business in addition to its flagship resourcing and FSP businesses.

Jul-2019: GVK BIO teamed up with BE Pharmaceuticals Inc. (BE Inc), a company that develops, manufactures, and markets complex and critical injectable products. Under this partnership, GVK BIO is expected to develop a certain set of injectable products for BE Inc. The aim of the collaboration is the successful regulatory submissions and marketing authorizations for the products in the US, Europe, and RoW markets.

Acquisition and Mergers:

Oct-2019: ICON took over Symphony Clinical Research, a global leader in clinical research. The acquisition enabled the company in minimizing travel burden for patients by providing them access to clinical research studies that they have otherwise not been able to participate in.

Sep-2019: Accelerated Enrollment Solutions (AES), a business of Pharmaceutical Product Development, LLC (PPD) took over the clinical research site business of Bioclinica. The acquisition expanded AES' global foothold and its leadership position in patient access and site conduct.

May-2019: Evidera, a business of Pharmaceutical Product Development, LLC (PPD) signed a definitive agreement to acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries. The acquisition is expected to enable the former company in providing its customers with enhanced technology solutions, real-world data, and access to health care providers.

May-2019: ICON announced the acquisition of a majority stake in MeDiNova Research, a site network with research sites in key markets in Europe and Africa. The acquisition enhanced the former company's patient recruitment capabilities in EMEA and complemented its site network in the US, PMG Research.

May-2019: Pharmaron acquired a majority stake in CR Medicon Holding Inc. (together with its wholly-owned subsidiary, Nanjing CR Medicon Pharmaceutical Technology Co., Ltd. “CR Medicon”), a clinical CRO based in Nanjing, China. The acquisition aimed to expand the clinical development services.

Product Launches and Product Expansions:

Feb-2020: IQVIA launched Avacare Clinical Research Network, a technology-based global site network. This network opens opportunities for more clinical trials at experienced clinical and research sites. Avacare's unique analytical tools help sites in Avacare's network in matching patients to clinical trials faster and more effectively.

Jan-2020: LabCorp and Covance introduced Extensive Preclinical, Clinical and Post-Approval Cell, and Gene Therapy Development. These solutions is expected to minimize time and risk for sponsors at each phase and across the full continuum of their therapy development needs in one of the industry's fastest-growing segments.

Aug-2019: IQVIA unveiled the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. The portal allows increases in clinical trial patient recruitment, engagement, and retention by ensuring transparency and collaboration before, during, and, after a clinical study.

Aug-2019: Laboratory Corporation announced that its Covance Drug Development arm launched a laboratory solution within its functional service provider (FSPx) portfolio. This new laboratory data management FSPx is expected to serve to the pharmaceutical and biotechnology customers.

May-2019: ICON launched a web-based patient engagement platform. The platform provides patients with study-specific information and connectivity with the nearest investigative site.

Feb-2019: IQVIA introduced IQVIA Biotech and its new approach for delivering tailored clinical and commercial solutions for small biotech and biopharma companies. This approach is expected to provide simplified operating procedures, specialized teams, and services for offering a more agile way for innovators to reach their drug development and commercialization milestones.

Feb-2019: LabCorp released the DoseASSURE, a new assay in its therapeutic drug monitoring (TDM). The new Certolizumab Concentration and Anti-Certolizumab Antibody DoseASSURE CTZ assay help the physicians in monitoring individual drug response for patients who are on Certolizumab, a biologic drug used for the treatment of certain inflammatory diseases, such as rheumatoid arthritis and Crohn's disease.

Jan-2019: IQVIA released two new capabilities for supporting clinical teams in more easily and quickly sharing cross-trial training materials and safety notifications.

Scope of the Study

Market Segmentation:

Asia Pacific Healthcare CRO Market Segmentation

By Service Type
  • Clinical Research Services
  • Early Phase Development
  • Laboratory Services and
  • Consulting Services
By End User
  • Pharmaceutical companies
  • Medical Device Companies and
  • Academic Institutes
By Therapeutic Area
  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Diabetes
  • Metabolic Diseases
  • Infectious Diseases and
  • Other therapeutic areas
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Pharmaceutical Product Development, Inc.
  • Parexel International Corporation (Pamplona Capital Management)
  • Charles River Laboratories International, Inc.
  • ICON PLC
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Syneos Health, Inc.
  • Pharmaron Beijing Co., Ltd.
  • GVK Biosciences Private Limited
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ICON PLC
  • IQVIA Holdings, Inc.
  • Syneos Health, Inc.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Healthcare CRO Services Market, by Service Type
1.4.2 Global Healthcare CRO Services Market, by End User
1.4.3 Global Healthcare CRO Services Market, by Therapeutic Area
1.4.4 Global Healthcare CRO Services Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Aug – 2020, Mar) Leading Players

Chapter 4. Global Healthcare CRO Services Market by Service Type
4.1 Global Clinical Research Services Market by Region
4.2 Global Early Phase Development Market by Region
4.3 Global Laboratory Services Market by Region
4.4 Global Consulting Services Market by Region

Chapter 5. Global Healthcare CRO Services Market by End User
5.1 Global Pharmaceutical Sector Market by Region
5.2 Global Medical Device Sector Market by Region
5.3 Global Academic Institutes Market by Region

Chapter 6. Global Healthcare CRO Services Market by Therapeutic Area
6.1 Global Oncology Market by Region
6.2 Global CNS Disorder Market by Region
6.3 Global Cardiovascular Disease Market by Region
6.4 Global Diabetes Market by Region
6.5 Global Metabolic Diseases Market by Region
6.6 Global Infectious Diseases Market by Region
6.7 Global Other therapeutic areas Market by Region

Chapter 7. Global Healthcare CRO Services Market by Region
7.1 North America Healthcare CRO Services Market
7.1.1 North America Healthcare CRO Services Market by Service Type
7.1.1.1 North America Clinical Research Services Market by Country
7.1.1.2 North America Early Phase Development Market by Country
7.1.1.3 North America Laboratory Services Market by Country
7.1.1.4 North America Consulting Services Market by Country
7.1.2 North America Healthcare CRO Services Market by End User
7.1.2.1 North America Pharmaceutical Sector Market by Country
7.1.2.2 North America Medical Device Sector Market by Country
7.1.2.3 North America Academic Institutes Market by Country
7.1.3 North America Healthcare CRO Services Market by Therapeutic Areas
7.1.3.1 North America Oncology Market by Country
7.1.3.2 North America CNS Disorder Market by Country
7.1.3.3 North America Cardiovascular Disease Market by Country
7.1.3.4 North America Diabetes Market by Country
7.1.3.5 North America Metabolic Diseases Market by Country
7.1.3.6 North America Infectious Diseases Market by Country
7.1.3.7 North America Other therapeutic areas Market by Country
7.1.4 North America Healthcare CRO Services Market by Country
7.1.4.1 US Healthcare CRO Services Market
7.1.4.1.1 US Healthcare CRO Services Market by Service Type
7.1.4.1.2 US Healthcare CRO Services Market by End User
7.1.4.1.3 US Healthcare CRO Services Market by Therapeutic Areas
7.1.4.2 Canada Healthcare CRO Services Market
7.1.4.2.1 Canada Healthcare CRO Services Market by Service Type
7.1.4.2.2 Canada Healthcare CRO Services Market by End User
7.1.4.2.3 Canada Healthcare CRO Services Market by Therapeutic Areas
7.1.4.3 Mexico Healthcare CRO Services Market
7.1.4.3.1 Mexico Healthcare CRO Services Market by Service Type
7.1.4.3.2 Mexico Healthcare CRO Services Market by End User
7.1.4.3.3 Mexico Healthcare CRO Services Market by Therapeutic Areas
7.1.4.4 Rest of North America Healthcare CRO Services Market
7.1.4.4.1 Rest of North America Healthcare CRO Services Market by Service Type
7.1.4.4.2 Rest of North America Healthcare CRO Services Market by End User
7.1.4.4.3 Rest of North America Healthcare CRO Services Market by End User
7.2 Europe Healthcare CRO Services Market
7.2.1 Europe Healthcare CRO Services Market by Service Type
7.2.1.1 Europe Clinical Research Services Market by Country
7.2.1.2 Europe Early Phase Development Market by Country
7.2.1.3 Europe Laboratory Services Market by Country
7.2.1.4 Europe Consulting Services Market by Country
7.2.2 Europe Healthcare CRO Services Market by End User
7.2.2.1 Europe Pharmaceutical Sector Market by Country
7.2.2.2 Europe Medical Device Sector Market by Country
7.2.2.3 Europe Academic Institutes Market by Country
7.2.3 Europe Healthcare CRO Services Market by Therapeutic Areas
7.2.3.1 Europe Oncology Market by Country
7.2.3.2 Europe CNS Disorder Market by Country
7.2.3.3 Europe Cardiovascular Disease Market by Country
7.2.3.4 Europe Diabetes Market by Country
7.2.3.5 Europe Metabolic Diseases Market by Country
7.2.3.6 Europe Infectious Diseases Market by Country
7.2.3.7 Europe Other therapeutic areas Market by Country
7.2.4 Europe Healthcare CRO Services Market by Country
7.2.4.1 Germany Healthcare CRO Services Market
7.2.4.1.1 Germany Healthcare CRO Services Market by Service Type
7.2.4.1.2 Germany Healthcare CRO Services Market by End User
7.2.4.1.3 Germany Healthcare CRO Services Market by Therapeutic Areas
7.2.4.2 UK Healthcare CRO Services Market
7.2.4.2.1 UK Healthcare CRO Services Market by Service Type
7.2.4.2.2 UK Healthcare CRO Services Market by End User
7.2.4.2.3 UK Healthcare CRO Services Market by Therapeutic Areas
7.2.4.3 France Healthcare CRO Services Market
7.2.4.3.1 France Healthcare CRO Services Market by Service Type
7.2.4.3.2 France Healthcare CRO Services Market by End User
7.2.4.3.3 France Healthcare CRO Services Market by Therapeutic Areas
7.2.4.4 Russia Healthcare CRO Services Market
7.2.4.4.1 Russia Healthcare CRO Services Market by Service Type
7.2.4.4.2 Russia Healthcare CRO Services Market by End User
7.2.4.4.3 Russia Healthcare CRO Services Market by Therapeutic Areas
7.2.4.5 Spain Healthcare CRO Services Market
7.2.4.5.1 Spain Healthcare CRO Services Market by Service Type
7.2.4.5.2 Spain Healthcare CRO Services Market by End User
7.2.4.5.3 Spain Healthcare CRO Services Market by Therapeutic Areas
7.2.4.6 Italy Healthcare CRO Services Market
7.2.4.6.1 Italy Healthcare CRO Services Market by Service Type
7.2.4.6.2 Italy Healthcare CRO Services Market by End User
7.2.4.6.3 Italy Healthcare CRO Services Market by Therapeutic Areas
7.2.4.7 Rest of Europe Healthcare CRO Services Market
7.2.4.7.1 Rest of Europe Healthcare CRO Services Market by Service Type
7.2.4.7.2 Rest of Europe Healthcare CRO Services Market by End User
7.2.4.7.3 Rest of Europe Healthcare CRO Services Market by Therapeutic Areas
7.3 Asia Pacific Healthcare CRO Services Market
7.3.1 Asia Pacific Healthcare CRO Services Market by Service Type
7.3.1.1 Asia Pacific Clinical Research Services Market by Country
7.3.1.2 Asia Pacific Early Phase Development Market by Country
7.3.1.3 Asia Pacific Laboratory Services Market by Country
7.3.1.4 Asia Pacific Consulting Services Market by Country
7.3.2 Asia Pacific Healthcare CRO Services Market by End User
7.3.2.1 Asia Pacific Pharmaceutical Sector Market by Country
7.3.2.2 Asia Pacific Medical Device Sector Market by Country
7.3.2.3 Asia Pacific Academic Institutes Market by Country
7.3.3 Asia Pacific Healthcare CRO Services Market by Therapeutic Areas
7.3.3.1 Asia Pacific Oncology Market by Country
7.3.3.2 Asia Pacific CNS Disorder Market by Country
7.3.3.3 Asia Pacific Cardiovascular Disease Market by Country
7.3.3.4 Asia Pacific Diabetes Market by Country
7.3.3.5 Asia Pacific Metabolic Diseases Market by Country
7.3.3.6 Asia Pacific Infectious Diseases Market by Country
7.3.3.7 Asia Pacific Other therapeutic areas Market by Country
7.3.4 Asia Pacific Healthcare CRO Services Market by Country
7.3.4.1 China Healthcare CRO Services Market
7.3.4.1.1 China Healthcare CRO Services Market by Service Type
7.3.4.1.2 China Healthcare CRO Services Market by End User
7.3.4.1.3 China Healthcare CRO Services Market by Therapeutic Areas
7.3.4.2 Japan Healthcare CRO Services Market
7.3.4.2.1 Japan Healthcare CRO Services Market by Service Type
7.3.4.2.2 Japan Healthcare CRO Services Market by End User
7.3.4.2.3 Japan Healthcare CRO Services Market by Therapeutic Areas
7.3.4.3 India Healthcare CRO Services Market
7.3.4.3.1 India Healthcare CRO Services Market by Service Type
7.3.4.3.2 India Healthcare CRO Services Market by End User
7.3.4.3.3 India Healthcare CRO Services Market by End User
7.3.4.4 South Korea Healthcare CRO Services Market
7.3.4.4.1 South Korea Healthcare CRO Services Market by Service Type
7.3.4.4.2 South Korea Healthcare CRO Services Market by End User
7.3.4.4.3 South Korea Healthcare CRO Services Market by End User
7.3.4.5 Singapore Healthcare CRO Services Market
7.3.4.5.1 Singapore Healthcare CRO Services Market by Service Type
7.3.4.5.2 Singapore Healthcare CRO Services Market by End User
7.3.4.5.3 Singapore Healthcare CRO Services Market by End User
7.3.4.6 Malaysia Healthcare CRO Services Market
7.3.4.6.1 Malaysia Healthcare CRO Services Market by Service Type
7.3.4.6.2 Malaysia Healthcare CRO Services Market by End User
7.3.4.6.3 Malaysia Healthcare CRO Services Market by End User
7.3.4.7 Rest of Asia Pacific Healthcare CRO Services Market
7.3.4.7.1 Rest of Asia Pacific Healthcare CRO Services Market by Service Type
7.3.4.7.2 Rest of Asia Pacific Healthcare CRO Services Market by End User
7.3.4.7.3 Rest of Asia Pacific Healthcare CRO Services Market by End User
7.4 LAMEA Healthcare CRO Services Market
7.4.1 LAMEA Healthcare CRO Services Market by Service Type
7.4.1.1 LAMEA Clinical Research Services Market by Country
7.4.1.2 LAMEA Early Phase Development Market by Country
7.4.1.3 LAMEA Laboratory Services Market by Country
7.4.1.4 LAMEA Consulting Services Market by Country
7.4.2 LAMEA Healthcare CRO Services Market by End User
7.4.2.1 LAMEA Pharmaceutical Sector Market by Country
7.4.2.2 LAMEA Medical Device Sector Market by Country
7.4.2.3 LAMEA Academic Institutes Market by Country
7.4.3 LAMEA Healthcare CRO Services Market by Therapeutic Areas
7.4.3.1 LAMEA Oncology Market by Country
7.4.3.2 LAMEA CNS Disorder Market by Country
7.4.3.3 LAMEA Cardiovascular Disease Market by Country
7.4.3.4 LAMEA Diabetes Market by Country
7.4.3.5 LAMEA Metabolic Diseases Market by Country
7.4.3.6 LAMEA Infectious Diseases Market by Country
7.4.3.7 LAMEA Other therapeutic areas Market by Country
7.4.4 LAMEA Healthcare CRO Services Market by Country
7.4.4.1 Brazil Healthcare CRO Services Market
7.4.4.1.1 Brazil Healthcare CRO Services Market by Service Type
7.4.4.1.2 Brazil Healthcare CRO Services Market by End User
7.4.4.1.3 Brazil Healthcare CRO Services Market by Therapeutic Area
7.4.4.2 Argentina Healthcare CRO Services Market
7.4.4.2.1 Argentina Healthcare CRO Services Market by Service Type
7.4.4.2.2 Argentina Healthcare CRO Services Market by End User
7.4.4.2.3 Argentina Healthcare CRO Services Market by Therapeutic Area
7.4.4.3 UAE Healthcare CRO Services Market
7.4.4.3.1 UAE Healthcare CRO Services Market by Service Type
7.4.4.3.2 UAE Healthcare CRO Services Market by End User
7.4.4.3.3 UAE Healthcare CRO Services Market by Therapeutic Area
7.4.4.4 Saudi Arabia Healthcare CRO Services Market
7.4.4.4.1 Saudi Arabia Healthcare CRO Services Market by Service Type
7.4.4.4.2 Saudi Arabia Healthcare CRO Services Market by End User
7.4.4.4.3 Saudi Arabia Healthcare CRO Services Market by Therapeutic Area
7.4.4.5 South Africa Healthcare CRO Services Market
7.4.4.5.1 South Africa Healthcare CRO Services Market by Service Type
7.4.4.5.2 South Africa Healthcare CRO Services Market by End User
7.4.4.5.3 South Africa Healthcare CRO Services Market by Therapeutic Area
7.4.4.6 Nigeria Healthcare CRO Services Market
7.4.4.6.1 Nigeria Healthcare CRO Services Market by Service Type
7.4.4.6.2 Nigeria Healthcare CRO Services Market by End User
7.4.4.6.3 Nigeria Healthcare CRO Services Market by Therapeutic Area
7.4.4.7 Rest of LAMEA Healthcare CRO Services Market
7.4.4.7.1 Rest of LAMEA Healthcare CRO Services Market by Service Type
7.4.4.7.2 Rest of LAMEA Healthcare CRO Services Market by End User
7.4.4.7.3 Rest of LAMEA Healthcare CRO Services Market by Therapeutic Area

Chapter 8. Company Profiles
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
3 of 4
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Pharmaceutical Product Development, Inc.
  • Parexel International Corporation (Pamplona Capital Management)
  • Charles River Laboratories International, Inc.
  • ICON PLC
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Syneos Health, Inc.
  • Pharmaron Beijing Co., Ltd.
  • GVK Biosciences Private Limited
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll